Background As a consequence of the increase in life expectancy, hepatobiliary surgeons have to deal with an emerging aged population. We aimed to analyze the liver function and outcome after right hepatectomy (RH) in patients over 70 years of age. Methods From January 2006 to December 2009, we prospectively collected data of 207 consecutive elective hepatectomies. In patients who had RH, cardiac risk was assessed by a dedicated preoperative workup. Liver failure (LF) was defined by the ''fifty-fifty'' criteria at postoperative day 5 (POD) and morbidity by the Clavien-Dindo classification. Liver function tests (LFTs) and short-term outcome were retrospectively analyzed in patients over (elderly group, EG) and younger (young group, YG) than 70 years of age. Results Eighty-seven consecutive RH were performed during the study period. Indication for surgery included 90 % malignancy in 47 % of patients requiring preoperative chemotherapy. ASA grade [ 2 (44 vs. 16 %, p = 0.027), ischemic heart disease (17 vs. 5 %, p = 0.076), and preoperative cardiac failure (26 vs. 2 %, p \ 0.001) were more frequent in the EG (n = 23) than in the YG (n = 64). Both groups were similar regarding rates of normal liver parenchyma, chemotherapy and intraoperative parameters.
Introduction
Surgery in the elderly has become very common. In fact, due to increased life expectancy worldwide [1, 2] , hepatobiliary (HPB) surgeons are dealing with an emerging aged population, which is expected to have a higher risk of postoperative complications and possibly adverse long-term outcomes. On the other hand, due to improvement in perioperative management, liver surgery is considered safe today [3] , and several series have investigated the outcome of elderly patients after liver surgery [4] [5] [6] [7] . These series assessed various indications and types of liver resection together and included patients with various underlying liver parenchyma. However, the cutoff for age was not always the same, with a few series using 65 years to define the elderly population, and others using 70 or even 75 [8] [9] [10] .
The aging process is a biological reality but its influence on the function of organs like the liver remains controversial. Recently, comparable outcomes in graft failure and patient survival after transplantation of livers from donors older or younger than 70 years were reported, suggesting that liver function is not altered with age [11] [12] [13] [14] . According to published data within the last decade [9, 10, 15, 16] , minor liver resections (i.e., resections of \3 Couinaud's segment) can be performed safely in the elderly whatever the quality of the underlying parenchyma. In the case of right hepatectomy, the volume of the future liver remnant (FLR) and the quality of the underlying liver parenchyma are of primary concern for the postoperative outcome.
There is some evidence that major hepatectomy is well tolerated in older patients, however, the mortality risk ranges from 6 to 10 % in larger series [6, 8, 10, 17] . On the other hand, the data on the specific risks of right hepatectomy in patients over 70 years of age are scarce and lack standardization in terms of patient risk assessment, particularly for cardiac risk. In this setting, two questions are still debated about elderly patients and are the end points of our present study: (1) Are the functional reserve and regenerative capacity of the liver sufficient to tolerate a parenchymal reduction of 60 % or more? and (2) What is the impact of a right hepatectomy on postoperative cardiac function and patient outcome?
Patients and Methods
From January 2006 to December 2009, we prospectively collected all demographic, clinical, and laboratory data of patients who underwent elective liver resection in our tertiary referral university center. During the study period, all consecutive patients older (Elderly group, EG) and younger (Young group, YG) than 70 years old were assessed with a dedicated workup before undergoing right or extended right hepatectomy. Morbidity, mortality, and liver function were systematically recorded in both groups and data were analyzed retrospectively. The local ethics committee approved this study which was registered at ClinicalTrial.gov (NCT01471262).
Preoperative Assessment
All treatment strategies and indications for surgery were discussed by a multidisciplinary board. Before surgery, a senior HPB surgeon and an anesthetist assessed all patients in the outpatient clinic. The American Society of Anesthesiologists (ASA) grade was used to evaluate the patients' operative risk. Preoperative investigations included electrocardiogram and chest radiograph with blood sampling for all patients (white blood cell count, liver function tests, and creatinine levels). Preoperative cardiac risk assessment followed the guidelines for noncardiac surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anesthesiology (ESA) [18, 19] . Briefly, the diagnostic algorithm for risk stratification of myocardial infarction and left ventricular (LV) function was similar to that proposed for patients in the nonsurgical setting with known or suspected ischemic heart disease (IHD). Noninvasive testing included echocardiography, exercise electrocardiogram, or stress myocardial scintigraphy after assessment by a senior cardiologist from our institution. Invasive testing included coronary angiography with corrective intervention if necessary. Preoperative cardiac failure was defined as left ventricular ejection fraction of\50 % during echocardiography.
Prior to surgery, all patients had a high-resolution contrast-enhanced CT scan of the chest and abdomen. The aim of this imaging was to assess the liver volume, vascular anatomy, and the extent of the hepatic lesion and to rule out extrahepatic disease in cases of malignancy. If necessary, preoperative portal vein embolization (PVE) was performed according to the standard technique [20] . The indications for PVE included a future remnant liver volume \25 % in normal parenchyma, \30 % in cases of multiple cycles of chemotherapy (more than 6), and \40 % in cases of cirrhosis [21] . Patients with preoperative biliary obstruction and jaundice underwent percutaneous or endoscopic drainage prior to surgery. The following preoperative characteristics were also analyzed: renal function, obesity as defined by the World Health Organization (i.e., BMI C 30 kg/m 2 ) [22] , hypertension, diabetes mellitus, chronic obstructive pulmonary disease (COPD), and chemotherapy in patients with malignancy. Renal failure was defined preoperatively as creatinine clearance below 50 ml/min (Cockcroft formula) or if patients were under chronic hemodialysis.
Intraoperative Data
Liver resections were classified according to the Brisbane nomenclature [23] . Right hepatectomy was defined by the resection of liver Couinaud's segments V, VI, VII, and VIII, and extended right hepatectomy was defined by the resection of additional segments IV and/or I. Extended right hepatectomy was indicated in patients with an extensive tumor or vascular invasion. The surgical procedure included parenchyma transection using an ultrasonic dissector, and intermittent pedicle clamping without preconditioning (Pringle maneuver) was reserved only for the cases of bleeding. Hemostasis was achieved with bipolar coagulation, hemoclips, and ligatures.
During parenchymal transection the central venous pressure was maintained below 5 cmH 2 O to prevent venous hemorrhage and cardiac overload. The following intraoperative data were also collected: additional nonhepatic surgery, intermittent clamping duration, total venous exclusion of the liver (TVE), need for transfusion, and operative duration.
Postoperative Care and Outcome Analysis
All patients who underwent a right or extended right hepatectomy were transferred postoperatively to the intensive care unit (ICU) or to the surgical intermediate care unit of our hospital. This was first to maintain the fluid balance, second for cardiac monitoring, and third for respiratory management. Postoperative morbidity was assessed using the validated classification system by Clavien-Dindo [24] . Serious complications were categorized as grades III-V and defined as morbidity requiring surgical or radiological intervention (under local or general anesthesia), ICU transfer with single-or multiple-organ failure, or death. In addition, the following specific liver complications were recorded: postoperative ascites, biliary leak, and liver failure. Postoperative transaminase (AST and ALT) levels, total bilirubin (TB) levels, and prothrombin time (PT) were recorded daily until postoperative day (POD) 8. Liver failure was defined as a bilirubin level of more than 50 mmol/l and prothrombin index \50 % of normal value at POD 5 according to the ''fifty-fifty'' criteria [25] . Postoperative pulmonary morbidity was also analyzed, including pulmonary embolism (PE), lung infection requiring intravenous antibiotic therapy with or without invasive ventilatory support, and pleural effusion requiring drainage. Postoperative mortality was defined as any death occurring within 90 days after surgery.
Histopathological Analysis
All liver specimens were sent for histopathological assessment after surgery. A specialized hepatobiliary pathologist analyzed the liver lesions and the quality of the underlying parenchyma. The extent of parenchyma fibrosis was assessed with the Metavir score [26] . Liver steatosis was categorized into two groups: less than or more than 30 % micro-or macrovesicular steatosis [27, 28] . Liver parenchyma with a fibrosis score of F0-F2 and/or with \30 % steatosis was considered ''normal'' [28] .
Statistical Analysis
The Fisher exact test or the v 2 test was used for categorical variables and the Student t test or one-way ANOVA was used for continuous variables where appropriate. The results were expressed as mean and standard deviation (SD) or median and range. The current clinical relevant risk factors for major postoperative complications (grade III-V) in the elderly (i.e., ASA grade, preoperative renal and cardiac failure, ischemic heart disease, diabetes, obesity, hypertension, transfusion, additional surgery, and chemotherapy) were included in the univariate analysis and proportions were compared according to the two age groups (C or \70 years old). Statistical analyses were performed using SPSS for Windows v18 (SPSS Inc., Chicago, IL). Statistical significance was accepted as p \ 0.05 (2-sided tests).
Results
During the study period, a total of 207 consecutive patients who underwent hepatectomy were collected in the database, including 87 right or extended right hepatectomies, which correspond to the study cohort (Fig. 1 ). The median age was 60 years (range = 21-85) and the male/female ratio was 55/32. Additional nonhepatic surgery was required in 33 % of the patients. The main indication for surgery was malignancy in 90 % (n = 78), including 47 % who underwent preoperative chemotherapy. Liver parenchyma was normal in 78 % of the specimens and the overall liver failure rate was 5 %. Overall, postoperative morbidity and 90-day mortality rates were 29 % and 4.6 %, respectively. Twenty-six percent of the patients (n = 23) were older than 70 years of age. In the EG versus the YG, preoperative characteristics were comparable, except for the ASA grade, cardiac failure, and IHD rates, which were higher in the EG (Table 1 ). Of note, two patients (9 %) in the EG required cardiac angiography with dilatation due to significant coronary artery stenosis diagnosed in the preoperative workup. Indication for surgery was mainly malignancy in both groups (95 vs. 88 %, p = 0.434), and the rate of preoperative chemotherapy was similar. In hepatocellular carcinoma (HCC) patients (n = 21), hepatitis B serology was positive in one patient [70 years old and in four patients \70 years old. Hepatitis C serology was negative in all patients[70 years old and positive in one patient \70 years old. As listed in Table 2 Table 3 summarizes the postoperative outcomes. The overall complication rate was not different between the elderly and young patients, but for grades III-V morbidity tended to be higher in the EG (39 vs. 25 %, p = 0.199). Of note, there were more cardiac complications but no liver failures in the EG. The rates of liver-and pulmonary-related complications were not different between the two groups. The median hospital stay for the EG was of 17 days (IQR = 13-29) compared with 15 days (IQR = 11-22) for the YG (p = 0.363), and the 90-day mortality rate was 9 versus 3 % (p = 0.281), respectively. The two deaths in the EG were due to heart failure. The first fatality was a patient with an ASA grade of III, cardiac insufficiency, and IHD, and the second was an ASA III patient with diabetes but with no previous history of cardiac disease and a normal preoperative cardiac workup. In the YG, the two deaths were related to liver failure leading to multiple-organ failure in the context of cirrhosis. These two patients were 59 and 63 years old, obese (BMI = 32 and 31, respectively) and with an ASA grade of III. They both developed HCC secondary to alcohol-induced cirrhosis and nonalcoholic steatohepatitis (biopsy-proven), respectively. Serologies for hepatitis B and C were negative in both cases. Of note, the second patient had preoperative transarterial chemoembolization (TACE) followed by PVE due to a large tumor size (7.5 9 6 cm diameter). Finally, the future liver remnant volume was 38 and 40 % of the total initial liver volume on the preoperative CI confidence interval, COPD chronic obstructive pulmonary disease a Hepatocellular carcinoma (n = 21), colorectal liver metastases (n = 35), cholangiocarcinoma (n = 8), gallbladder cancer (n = 1), other metastases (n = 10) b In small numbers, it is common to have overestimated odds ratio. This result should be taken with caution CT scan for EG and YG, respectively. Surgery was uneventful; however, in two patients a diaphragmatic resection was required due to tumor invasion. In the postoperative course, both patients had liver failure according to the ''fifty-fifty'' criteria, complicated by infected ascites, ventilator-associated pneumonia, and hepatorenal syndrome. Despite supportive care in the ICU with renal replacement therapy, both patients died from multiple-organ failure at days 15 and 31, respectively. In both cases, the nontumoral liver parenchyma analysis showed cirrhosis with microvesicular steatosis of more than 40 %.
Additional univariate analysis assessing the factors associated with major postoperative complications showed that patients older than 70 years and with diabetes were particularly at risk for grade III-V complications (Table 4) . In this setting major morbidity was related to one cardiac failure, one ischemic colon perforation, and one biliary peritonitis secondary to Roux-en-Y leakage. Of note, there was a trend toward higher major complications in the elderly who had additional nonhepatic surgery versus those who did not (67 vs. 35 %, p = 0.110) and transfusions (44 vs. 30 %, p = 0.523). [24] b According to the ''fifty-fifty'' criteria at POD 5 [25] c Odds ratio could not be calculated because of the presence of a zero in the variables (Fig. 3) . Finally, only ALT levels were significantly higher at POD 1 and 3 in the YG (median = 413 vs. 275 mmol/l and 244 vs. 174 mmol/l, p = 0.046 and p = 0.048, respectively).
Histopathological Analysis
In the elderly versus the young patients, the analysis of perilesional liver parenchyma showed a similar rate of normal parenchyma (78 % in both groups, p = 0.991), with similar rates of F3-F4 fibrosis (22 vs. 19 %, p = 0.762) and macrovesicular steatosis C30 % (9 vs. 5 %, p = 0.480).
Discussion
The results of our study suggest that age over 70 years alone is not a contraindication to right hepatectomy. Surgery did not increase the in-hospital mortality when compared to younger patients, and the functional reserve of the ''old liver'' was not altered. However, major morbidity was higher in the elderly with diabetes. Within the last decade, most studies reporting complications of patients who underwent a hepatectomy included both major and minor resections, without providing a subgroup analysis (Table 5 ). To date, four retrospective series [6, 8, 10, 17] investigated the outcome of elderly patients after major hepatectomy. However, it is difficult to interpret their results for three reasons. First, the preoperative workup used to assess elderly patients was neither stated nor standardized. Second, the type of major hepatectomy performed was varied and multiple (i.e., it included right and/or left hepatectomies). Third, the cutoff for age was not always the same (range = 60-75). Our study provides a homogeneous series of consecutive patients older and younger than 70 years of age who underwent a standardized risk assessment workup before formal right hepatectomy. As expected, elderly patients had more IHD ischemic heart disease, CI confidence interval a Odds ratio could not be calculated because of the presence of a zero in the variables cardiac comorbidities. Nevertheless, their 90-day mortality rate was not different than that of younger patients and was in accordance with the 0-10 % reported rates after major hepatectomy [5, 6, 8-10, 15, 17] . Of note, the dedicated workup allowed us to correct potential life-threatening cardiac disease before hepatic surgery in nearly 10 % of the elderly patients. Formerly, the most frequently reported causes of death in the elderly without any underlying disease were hepatic failure, myocardial infarction, renal failure, pneumonia, and gastrointestinal bleeding [29] [30] [31] .
Currently, monitoring a low central venous pressure during hepatic transection with intraoperative fluid restriction allowed the reduction of the risk of congestive heart failure and arrhythmias, which are the most dangerous complications encountered after major liver resections in the elderly [8, 10] . Surprisingly, despite the dedicated preoperative workup and a low central venous pressure maintained during right hepatectomy in our patients, death was always related to postoperative cardiac failure in the elderly group. These results matched those of other published studies [3, 8] and may be explained by the limited predictive value of left ventricular (LV) function assessment for perioperative outcome [19] . Indeed, LV failure predicts with a sensitivity of 50 % the risk of perioperative nonfatal myocardial infarction or cardiac death after noncardiac surgery [32] . These results suggest that cardiac risk after right hepatectomy in the elderly should not be underestimated, even with normal preoperative workup, and that our method of cardiac assessment should not be withheld but it needs revision. After major hepatectomy in the elderly, the reported complication rate ranges from 30 to 50 % [6, 7, 10] . In our study, overall morbidity was comparable between the young and elderly groups. Pulmonary complications were not different, confirming what was found in previous reports [17] . This may be explained by the routine use of postoperative respiratory management and intraoperative fluid restriction. On the other hand, 39 % of the morbidity observed in our elderly patients referred to grade III-V complications. Except of the two cardiac failures that led to death, all other complications could be managed with ICU support, surgery, or endoscopic treatment, without affecting the length of in-hospital stay. Interestingly, patients over 70 years of age and with diabetes had a significantly increased risk for major complications. It is acknowledged that patients with diabetes are more prone to sepsis, atherosclerosis, and delayed healing [33] . In addition, patients with diabetes were associated with delayed ventilator weaning, more transfusions, and greater morbidity after liver resections [33, 34] . According to our results, the morbidity risk after right hepatectomy in patients with diabetes seems to be amplified by the aging process. We can speculate that vascular lesions induced by both factors may be involved in this risk, since most major complications had an ischemic etiology. As reported by others [3, 6, [35] [36] [37] , there was also a trend toward higher morbidity in the elderly who had additional nonhepatic surgery or transfusions.
Thus, there is a potentially greater risk for major complications after right hepatectomy in the elderly, but this morbidity is still acceptable for two reasons: (1) most patients were operated on for malignancy ([90 % HCC and colorectal liver metastases) and required a right hepatectomy to obtain a tumor-free margin, and (2) most complications were managed in the same way as in younger patients, without increasing the mortality risk or the length of hospital stay. Of note, 33-50 % of the patients with colorectal liver metastases were older than 70 years [7] . Moreover, liver resection offers a similar 5-year survival as that in younger patients [7, 38, 39] . These results were also confirmed in elderly patients with HCC [15, 16] . Therefore, surgery in the aged population should yield the same oncological results as in younger patients. To achieve this goal, a right or extended right hepatectomy may be necessary. An accepted policy to reduce the postoperative morbidity in these patients is then to avoid additional nonhepatic surgery and transfusion whenever possible. Finally, elderly patients with diabetes should have a dedicated preoperative workup and should be closely monitored postoperatively to anticipate fatal complications, mainly related to heart failures.
The aging process of the liver is still not fully understood and involves several changes in the liver architecture. For example, the size of the liver and the sinusoidal flow decrease with age [40, 41] , but their influence on liver function remains unclear. In our study, the rate of normal liver parenchyma was similar in patients older and younger than 70 years of age, suggesting that liver steatosis or fibrosis was not increase with age. Moreover, liver function tests had a similar trend throughout POD 1-8, confirming the results reported by Ettorre et al. [8] in patients over 65 years old. We added the ''fifty-fifty'' criteria [25] to show that the postoperative liver failure rate was not increased in patients over 70 years old, provided that liver parenchyma was prepared by PVE and biliary drainage when required. These results support the hypothesis that liver function is not significantly altered with age.
One of the limitations of this study is the small sample size of elderly patients; however, the incidence of right hepatectomy in patients over 70 years old is extremely low in many centers. Another limitation is that in the preoperative workup, we did not use (at that time) the indocyanine green (ICG) retention test [42, 43] . This test, widely used in Asian countries and some centers in Europe to assess liver function, may contribute further to assessing the postoperative outcome of patients who will undergo a right hepatectomy as it may correlate with the liver volume. Well-designed prospective multicenter trials that include the ICG retention test in the preoperative workup may further confirm our findings.
In conclusion, the present study confirms that right hepatectomy can be performed safely in patients over 70 years of age without increased morbidity, provided a careful cardiac and liver parenchyma assessment is performed. However, the major morbidity will be higher in elderly patients with diabetes and will tend to increase in those who need additional nonhepatic surgery or blood transfusions. Finally, age does not alter significantly the postoperative functional reserve of the liver. A similar analysis remains to be performed in patients above 80 years of age.
